Open an account

State Street SPDR S&P Pharmaceuticals ETF

XPH · ETF

$62.70−$1.58 (−2.46%)TodayMarket closed ·
Prev close $64.28

About XPH

XPH was created on 2006-06-19 by SPDR. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 461.41m in AUM and 64 holdings. XPH tracks an equal-weighted index of US pharmaceutical companies.

Issuer
SPDR
Tracks
S&P Pharmaceuticals Select Industry
Expense ratio
0.35%
Assets under management
$447.70M
Inception
Jun 19, 2006
Asset class
Equity
Website
ssga.com

XPH key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
204.45K
Volume
39.84K
Open price
$63.98
High today
$63.98
Low today
$62.46
52 Week high
$74.35
52 Week low
$47.60

State Street SPDR S&P Pharmaceuticals ETF (XPH) at a glance

As of Oct 23, 2026, State Street SPDR S&P Pharmaceuticals ETF (XPH) shares are priced at $62.70, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $62.46 and $63.98. The current price is 0.4% above the day's low and 2.0% below its high.

Volume so far is 39.84K shares, below the average of 204.45K shares a day.

Over the past year State Street SPDR S&P Pharmaceuticals ETF has ranged from $47.60 to $74.35, and now sits 56% of the way up that range.

XPH news

  • Stjepan Kalinic

    Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

  • Akanksha Bakshi

    Why Is Organon Stock Skyrocketing Monday?

  • Vandana Singh

    Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda

  • Nabaparna Bhattacharya

    Prestige Bets $1 Billion On World's Most Iconic Nasal Strip

  • Rishabh Mishra

    Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'

  • Chandrima Sanyal

    Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts

  • Rishabh Mishra

    Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'

  • Rishabh Mishra

    Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.